HK1117529A1 - Organic compound and method for producing radioactive halogen-labeled organic compound using the same - Google Patents

Organic compound and method for producing radioactive halogen-labeled organic compound using the same

Info

Publication number
HK1117529A1
HK1117529A1 HK08108510.6A HK08108510A HK1117529A1 HK 1117529 A1 HK1117529 A1 HK 1117529A1 HK 08108510 A HK08108510 A HK 08108510A HK 1117529 A1 HK1117529 A1 HK 1117529A1
Authority
HK
Hong Kong
Prior art keywords
organic compound
radioactive halogen
amino
same
syn
Prior art date
Application number
HK08108510.6A
Other languages
English (en)
Inventor
Masahito Toyama
Fumie Kurosaki
Akio Hayashi
Osamu Ito
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of HK1117529A1 publication Critical patent/HK1117529A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0404Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK08108510.6A 2005-05-23 2008-08-01 Organic compound and method for producing radioactive halogen-labeled organic compound using the same HK1117529A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005149186 2005-05-23
PCT/JP2006/309643 WO2006126410A1 (ja) 2005-05-23 2006-05-15 新規有機化合物及び該化合物を利用した放射性ハロゲン標識有機化合物の製造方法

Publications (1)

Publication Number Publication Date
HK1117529A1 true HK1117529A1 (en) 2009-01-16

Family

ID=37451836

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08108510.6A HK1117529A1 (en) 2005-05-23 2008-08-01 Organic compound and method for producing radioactive halogen-labeled organic compound using the same

Country Status (15)

Country Link
US (1) US7910745B2 (de)
EP (1) EP1889834B1 (de)
JP (1) JP4989467B2 (de)
KR (1) KR101315152B1 (de)
CN (1) CN101180272B (de)
AT (1) ATE506347T1 (de)
AU (1) AU2006250594B2 (de)
CA (1) CA2608919C (de)
DE (1) DE602006021418D1 (de)
DK (1) DK1889834T3 (de)
ES (1) ES2364463T3 (de)
HK (1) HK1117529A1 (de)
NO (1) NO20076411L (de)
TW (1) TWI410396B (de)
WO (1) WO2006126410A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060292073A1 (en) * 2005-06-23 2006-12-28 Emory University Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging
EP3354639B1 (de) * 2005-11-29 2024-02-21 Nihon Medi-Physics Co., Ltd. Vorläuferverbindung einer radioaktiven halogenmarkierten organischen verbindung
US8790620B2 (en) * 2006-12-21 2014-07-29 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
EP3530648B1 (de) * 2006-12-27 2023-11-08 Nihon Medi-Physics Co., Ltd Verfahren zur herstellung einer vorläuferverbindung für mit radioaktivem halogen markierte, organische verbindung
TWI406674B (zh) * 2007-02-13 2013-09-01 Nihon Mediphysics Co Ltd Method for manufacturing diagnostic radiographic diagnostic agents
JP5121349B2 (ja) * 2007-08-10 2013-01-16 株式会社トクヤマ アミノ酸の製造方法
CN102471235A (zh) * 2009-07-11 2012-05-23 拜耳医药股份有限公司 利用环烷基的放射性标记方法
JP2014501702A (ja) 2010-10-28 2014-01-23 ジーイー・ヘルスケア・リミテッド 放射性医薬品前駆体の安定化
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
WO2018235535A1 (ja) * 2017-06-23 2018-12-27 日本メジフィジックス株式会社 放射性ハロゲン標識化合物の製造方法および放射性医薬の製造方法
CN110724058A (zh) * 2019-10-25 2020-01-24 吉林凯莱英制药有限公司 反式环丁烷邻二羧酸酯及其衍生物的制备方法
US20220380292A1 (en) * 2019-10-25 2022-12-01 Jilin Asymchem Pharmaceuticals Co., Ltd. Preparation method for trans-cyclobutane-o-dicarboxylic acid ester and derivative thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
FR2841554B1 (fr) * 2002-07-01 2008-01-18 Commissariat Energie Atomique Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
GB0229695D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids

Also Published As

Publication number Publication date
TWI410396B (zh) 2013-10-01
DE602006021418D1 (de) 2011-06-01
US20090105489A1 (en) 2009-04-23
EP1889834A1 (de) 2008-02-20
CA2608919A1 (en) 2006-11-30
ES2364463T3 (es) 2011-09-02
NO20076411L (no) 2008-02-13
TW200704630A (en) 2007-02-01
CA2608919C (en) 2012-11-20
ATE506347T1 (de) 2011-05-15
JP4989467B2 (ja) 2012-08-01
EP1889834A4 (de) 2010-06-30
CN101180272A (zh) 2008-05-14
KR101315152B1 (ko) 2013-10-07
CN101180272B (zh) 2012-04-25
AU2006250594B2 (en) 2011-06-16
US7910745B2 (en) 2011-03-22
JPWO2006126410A1 (ja) 2008-12-25
AU2006250594A1 (en) 2006-11-30
DK1889834T3 (da) 2011-08-08
WO2006126410A1 (ja) 2006-11-30
KR20080016557A (ko) 2008-02-21
EP1889834B1 (de) 2011-04-20

Similar Documents

Publication Publication Date Title
HK1117529A1 (en) Organic compound and method for producing radioactive halogen-labeled organic compound using the same
ATE550319T1 (de) Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
WO2007021858A3 (en) Methods of making radiolabeled tracers and precursors thereof
TNSN06451A1 (en) Radiation curable composition consisting of unsaturated amorphous polyesters and reactive dilutant agents
TNSN07132A1 (en) Radiation curable modified, unsaturated, amorphous polyesters
WO2008132964A1 (ja) 3,3,3-トリフルオロプロピンの製造方法
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
BRPI0507347B8 (de)
PL2354235T3 (pl) Sposób fermentacyjnego wytwarzania L-aminokwasów z zastosowaniem bakterii maczugowatych
EP1958953A4 (de) Verfahren zur herstellung einer mit radioaktivem fluor markierten verbindung
WO2010093182A3 (ko) L-아미노산 생산용 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법
BR0304632B1 (pt) composiÇço e processo para realÇar a produÇço de biomassa em estufas.
ATE484575T1 (de) Mikroorganismus des genus corynebacterium der eine erhöhte l-lysinproduktivität hat und verfahren zur herstellung von l-lysin durch besagten mikroorganismus
ZA200800065B (en) Method for producing radiation curable formulations with increased corrosion protection on metal substrates, and formulations of this type
WO2010058129A3 (fr) Procede de fabrication de methylmercaptopropionaldehyde et de methionine a partir de matieres premieres renouvelables
WO2009102378A3 (en) Purification of 68ge/68ga generator eluate from fe(iii) intended to improve specific radioactivity of 68ga-based radiopharmaceuticals
GEP20135926B (en) Trazodone and trazodone hydrochloride in purified form
MX2010005015A (es) Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero.
EP2070937A4 (de) Verfahren zur herstellung einer mit radioaktivem fluor markierten organischen verbindung und entsprechender syntheseapparat und programm
FR2930265B1 (fr) Procede d'agglomeration de poussieres industrielles, en particulier par technique de briquetage
MX2009002258A (es) Procedimiento para producir 1-(3,4-diclorobencil)-5-octilbiguanida o una sal de la misma.
IL187640A0 (en) Method for preparing clopidogrel and intermediates used therein
ATE533086T1 (de) Lichtempfindliche zusammensetzung und verfahren zur strukturformung damit
SG147336A1 (en) Cleaning process and apparatus
WO2008081635A1 (ja) 含窒素化合物の製造方法

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220515